HU205009B - Process for producing synergetic pharmaceutical compositions comprising paf-antagonist and beta2-mimetic, suitable for treating asthma - Google Patents

Process for producing synergetic pharmaceutical compositions comprising paf-antagonist and beta2-mimetic, suitable for treating asthma Download PDF

Info

Publication number
HU205009B
HU205009B HU892181A HU218189A HU205009B HU 205009 B HU205009 B HU 205009B HU 892181 A HU892181 A HU 892181A HU 218189 A HU218189 A HU 218189A HU 205009 B HU205009 B HU 205009B
Authority
HU
Hungary
Prior art keywords
hydroxy
tert
methyl
butylamino
amino
Prior art date
Application number
HU892181A
Other languages
German (de)
English (en)
Hungarian (hu)
Other versions
HUT50291A (en
Inventor
Hubert Heuer
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of HUT50291A publication Critical patent/HUT50291A/hu
Publication of HU205009B publication Critical patent/HU205009B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU892181A 1988-05-06 1989-05-05 Process for producing synergetic pharmaceutical compositions comprising paf-antagonist and beta2-mimetic, suitable for treating asthma HU205009B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3815480A DE3815480A1 (de) 1988-05-06 1988-05-06 Synergistische kombinationen und ihre verwendung als therapeutika

Publications (2)

Publication Number Publication Date
HUT50291A HUT50291A (en) 1990-01-29
HU205009B true HU205009B (en) 1992-03-30

Family

ID=6353797

Family Applications (1)

Application Number Title Priority Date Filing Date
HU892181A HU205009B (en) 1988-05-06 1989-05-05 Process for producing synergetic pharmaceutical compositions comprising paf-antagonist and beta2-mimetic, suitable for treating asthma

Country Status (10)

Country Link
EP (1) EP0341559A3 (xx)
JP (1) JPH0211525A (xx)
KR (1) KR900017588A (xx)
AU (1) AU614362B2 (xx)
DE (1) DE3815480A1 (xx)
DK (1) DK220389A (xx)
HU (1) HU205009B (xx)
IL (1) IL90181A (xx)
NZ (1) NZ228999A (xx)
ZA (1) ZA893261B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
US5367638A (en) * 1991-12-23 1994-11-22 U.S. Philips Corporation Digital data processing circuit with control of data flow by control of the supply voltage
EE200200602A (et) * 2000-04-27 2004-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pikatoimelised beetamimeetikumid, meetod nende valmistamiseks ja nende kasutamine ravimitena
EP1993564A4 (en) * 2006-03-14 2010-05-26 Wholesome Biopharma Pty Ltd METHOD AND COMPOSITION FOR TREATING ALLERGIC DISEASES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3701344A1 (de) * 1986-01-21 1987-07-23 Boehringer Ingelheim Kg Neue thieno-1,4-diazepine

Also Published As

Publication number Publication date
KR900017588A (ko) 1990-12-19
AU614362B2 (en) 1991-08-29
EP0341559A2 (de) 1989-11-15
DE3815480A1 (de) 1989-11-16
DK220389A (da) 1989-11-07
EP0341559A3 (de) 1990-05-09
ZA893261B (en) 1991-01-30
JPH0211525A (ja) 1990-01-16
AU3406389A (en) 1989-11-09
DK220389D0 (da) 1989-05-05
IL90181A (en) 1993-07-08
HUT50291A (en) 1990-01-29
NZ228999A (en) 1991-07-26
IL90181A0 (en) 1989-12-15

Similar Documents

Publication Publication Date Title
Messing et al. Drug‐induced seizures: A 10‐year experience
AU775588B2 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
RU2475236C2 (ru) Способ получения фармацевтической композиции
JP2703906B2 (ja) 酸化に対して安定化された薬剤組成物
US6299861B1 (en) Ipratropium bromide enantiomer with prolonged duration of effect
HU178867B (en) Process for preparing synergetic analgetic composition containing nalbuphine and acetaminophene
TWI679030B (zh) 使用晶體工程及茶胺酸溶解之平台藥物遞送系統
US8440678B2 (en) Pharmaceutical composition
US20070041911A1 (en) Hfc solution formulations containing salbutamol hydrochloride or salbutamol citrate
CZ339199A3 (cs) Antitusické přípravky
CA2728514C (en) Paediatric compositions for treating multiple sclerosis
HU205009B (en) Process for producing synergetic pharmaceutical compositions comprising paf-antagonist and beta2-mimetic, suitable for treating asthma
CA1336686C (en) Method of inhibiting onset of or treating migraine headache using a thromboxane a- receptor antagonist
EP2694074B1 (en) Use of a2b adenosine receptor antagonists for treating heart failure and arrhythmia in post-myocardial infarction patients
EP3954374A1 (en) Pharmaceutical combination of pimozide and methotrexate and use thereof
EP1417961A1 (en) New pharmaceutical compositions containing a combination of ambroxol or bromhexine and isopropamide iodide
CN104321323A (zh) 碳环核苷及其医药用途和组合物
WO1995003800A1 (en) Non-racemic compositions of spirofluorenehydantoins
JP2003081846A (ja) 液状鎮咳去痰薬
AU2019201291A1 (en) Paediatric compositions for treating multiple sclerosis
NZ243613A (en) Tablet comprising praziquantel, pyrantel pamoate and oxantel pamoate in synergistic proportions for treatment of nematode infestations
JPH0132806B2 (xx)
MXPA06004782A (es) Formulacion oral antidepresiva que comprende acido acetilsalicilico para acelerar la presentacion de la accion

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee